Fulgent Genetics (NASDAQ:FLGT) PT Lowered to $25.00 at Piper Sandler

Fulgent Genetics (NASDAQ:FLGT – Free Report) had its price target decreased by Piper Sandler from $28.00 to $25.00 in a research note released on Wednesday morning, Benzinga reports. Piper Sandler currently has a neutral rating on the stock. Separately, UBS Group started coverage on Fulgent Genetics in a research report on Thursday, December 7th. They […]

Related Keywords

United States ,Jian Xie ,Piper Sandler ,Nuveen Asset Management ,Vanguard Group Inc ,Pricet Rowe Associates Inc ,Barclays Plc ,Securities Exchange Commission ,Fulgent Genetics Inc ,Fulgent Genetics ,Free Report ,Genetics Stock Down ,Exchange Commission ,Asset Management ,Occudo Quantitative Strategies ,Get Free Report ,Fulgent Genetics Daily ,